SCHEMBL13601561

SCHEMBL13601561

CNC(=O)CC1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10875055 0.84 CHRM2 (0.43)
SCHEMBL22458551 0.82 CHRM2 (0.42)
SCHEMBL8757492 0.77 HPGD (0.50)
SCHEMBL12528101 0.77 BTK (0.33)
SCHEMBL12528034 0.77 BTK (0.33)
Dimethylamine SCHEMBL27849641 0.76 CYP1A2 (0.44)
SCHEMBL1006102 0.76
SCHEMBL10154232 0.76 HPGD (0.49)
SCHEMBL15443047 0.74
SCHEMBL2911474 0.73 HPGD (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629468-B2 Neuroprotectants, analgesics or anticonvulsants JANSSEN PHARMACEUTICA NV (BE) 2009-12-08 US disclosed
EP-1332133-B1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2008-07-09 EP disclosed